Last reviewed · How we verify

NCT05798169

Impact of Acute Hospitalisation and Resistance Training on Muscle Architecture and Physical Performance in Older Adults

Completed NA Last updated 27 March 2025
What this trial tests

NA trial testing Resistance training in Sarcopenia in 274 participants. Completed in 20 December 2024.

Timeline
5 January 2023
Primary endpoint
20 December 2024
20 December 2024

Quick facts

Lead sponsorOdense University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment274
Start date5 January 2023
Primary completion20 December 2024
Estimated completion20 December 2024
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Odense University Hospital

Who can join

65 and older, any sex, with Sarcopenia or Functional Decline. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sarcopenia characterised by loss of muscle mass, muscle strength and physical performance burdens many older adults since the condition is related to functional decline. Periods of inactivity such as during hospitalisation leads to further functional decline. It has been reported that the loss of muscle mass associated with sarcopenia not only entails a decrease in muscle mass but also changes in muscle architecture. Knowledge on changes in muscle architecture is essential since it is one of the most important determinants on muscle strength and thus physical performance. The main objective of this study is to investigate changes in muscle architecture and physical performance during acute hospitalisation and after discharge in older adults and subsequently the effectiveness of resistance training of the lower limb during acute hospitalisation. If successful, our study could have a great impact on the individual, as well as societal level, due to a better understanding of the factors related to sarcopenia and the prevention of functional decline as a result of hospitalisation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Emerging Links Between Ferroptosis and Neurodegeneration: Implications for Disease Mechanisms and Nutraceutical Interventions.
    Ali A, Babar Q, Saeed A, Sergi D, et al · · 2025 · cited 2× · PMID 40475985 · DOI 10.1002/fsn3.70385

Verify or expand the search:

Other trials of Resistance training

Trials testing the same drug.

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other Odense University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05798169.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing